Literature DB >> 16735341

Review of NICE's recommendations, 1999-2005.

James Raftery1.   

Abstract

Mesh:

Year:  2006        PMID: 16735341      PMCID: PMC1471962          DOI: 10.1136/bmj.332.7552.1266

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

Review 1.  NICE: faster access to modern treatments? Analysis of guidance on health technologies.

Authors:  J Raftery
Journal:  BMJ       Date:  2001-12-01

2.  PHARMAC and availability of pharmaceuticals.

Authors:  Richard Porter; Roger T Mulder
Journal:  N Z Med J       Date:  2002-06-07

3.  Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis.

Authors:  Nancy Devlin; David Parkin
Journal:  Health Econ       Date:  2004-05       Impact factor: 3.046

4.  Comparing estimates of cost effectiveness submitted to the National Institute for Clinical Excellence (NICE) by different organisations: retrospective study.

Authors:  A H Miners; Martina Garau; Dogan Fidan; A J Fischer
Journal:  BMJ       Date:  2004-12-15

5.  Setting health care priorities in Oregon. Cost-effectiveness meets the rule of rescue.

Authors:  D C Hadorn
Journal:  JAMA       Date:  1991-05-01       Impact factor: 56.272

6.  Drug policy down under: Australia's pharmaceutical benefits scheme.

Authors:  Stephen J Duckett
Journal:  Health Care Financ Rev       Date:  2004
  6 in total
  23 in total

1.  Health economics and health technology assessment in Central and Eastern Europe: a dose of reality.

Authors:  L Gulácsi; E Orlewska; M Péntek
Journal:  Eur J Health Econ       Date:  2012-10

2.  Use of economic evaluation in decision making: evidence and recommendations for improvement.

Authors:  Steven Simoens
Journal:  Drugs       Date:  2010-10-22       Impact factor: 9.546

3.  NICE work: nice try.

Authors:  Sam Shuster
Journal:  BMJ       Date:  2006-06-10

Review 4.  How NICE may be outflanked.

Authors:  R E Ferner; Sarah E McDowell
Journal:  BMJ       Date:  2006-05-27

Review 5.  Economic evaluation and decision making in the UK.

Authors:  Martin J Buxton
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

6.  Making a decision to wait for more evidence: when the National Institute for Health and Clinical Excellence recommends a technology only in the context of research.

Authors:  Kalipso Chalkidou; Andrew Hoy; Peter Littlejohns
Journal:  J R Soc Med       Date:  2007-10       Impact factor: 5.344

7.  NICE: managing conflict.

Authors:  Steve Iliffe; Jill Manthorpe
Journal:  J R Soc Med       Date:  2008-01       Impact factor: 5.344

8.  Health technology assessments in England: an analysis of the NICE Medical Technologies Evaluation Programme.

Authors:  William Green; John Hutton
Journal:  Eur J Health Econ       Date:  2013-11-10

9.  Access with evidence development in the UK: past experience, current initiatives and future potential.

Authors:  Andrew Briggs; Karen Ritchie; Elisabeth Fenwick; Kalipso Chalkidou; Peter Littlejohns
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

10.  From rationing to rational: the evolving status of NICE.

Authors:  Rubin Minhas; Kiran Cr Patel
Journal:  J R Soc Med       Date:  2008-09       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.